Selectivity index, ratio of EC50 for agonist activity at mouse TRH-R1 expressed in HEK293 cells to EC50 for agonist activity at mouse TRH-R2 expressed in HEK293 cells
Reduction in volume of infarction in Sprague-Dawley rat model of MCA occlusion-induced focal cerebral ischemia assessed as infarcts volume at 10 umol/kg, iv administered immediately after reperfusion and measured 22 hrs after reperfusion (Rvb = 237.69 +/- 4.08 mm3)
Reduction in neurological score in Sprague-Dawley rat model of MCA occlusion-induced focal cerebral ischemia at 10 umol/kg, iv administered immediately after reperfusion and measured 22 hrs after reperfusion up to 7 days
Effect on mean latency time during acquisition trial in Sprague-Dawley rat model of MCA occlusion-induced memory impairment at 10 umol/kg, iv by passive avoidance test
Effect on mean latency time during retention trial in Sprague-Dawley rat model of MCA occlusion-induced memory impairment at 10 umol/kg, iv by passive avoidance test
Reduction in cognitive impairment in Sprague-Dawley rat assessed as increase in number of entries to platform zone during retention trial at 10 umol/kg, iv measured on day 6 by Morris water maze test (Rvb = 0.5 No_unit)
Reduction in cognitive impairment in Sprague-Dawley rat assessed as reduction in latency to first entry to platform zone during retention trial at 10 umol/kg, iv measured on day 6 by Morris water maze test (Rvb = 95.76 secs)
Inhibition of lipid peroxidation in brain homogenates of Sprague-Dawley rat model of 2 hrs MCA occlusion-induced focal cerebral ischemia assessed as reduction in MDA levels at 10 umol/kg, iv administered immediately after reperfusion and measured 22 hrs after reperfusion by TBARS assay
Increase in neuronal survival in Sprague-Dawley rat model of MCA occlusion-induced focal cerebral ischemia assessed as increase in neuronal density at hippocampal CA1 regions at 10 umol/kg, iv by Cresyl violet staining based microscopy
Neuroprotective activity in Sprague-Dawley rat model of MCA occlusion-induced memory impairment assessed as maximum latency time during acquisition trial at 10 umol/kg, iv by passive avoidance test (Rvb = 49 secs)
Neuroprotective activity in Sprague-Dawley rat model of MCA occlusion-induced memory impairment assessed as minimum latency time during acquisition trial at 10 umol/kg, iv by passive avoidance test (Rvb = 49 secs)